A Phase II Parallel Arm Study of Sacituzumab Govitecan-hziy in Patients with Advanced Thymoma and Thymic Carcinoma Read more
This protocol is for the use of CliniMACS CD34 Reagent System in a single patient with relapsed AML. Patient received salvage chemo and planned stem cell boost for cytopenias. Since donor is a haplo, plan is to give CD34 selected cells with some t cell add back. Read more
A PHASE 1B/2, MULTICENTER, OPEN-LABEL STUDY OF IFINATAMAB DERUXTECAN (I-DXd), A B7-H3 ANTIBODY-DRUG CONJUGATE (ADC), IN COMBINATION WITH ATEZOLIZUMAB WITH OR WITHOUT CARBOPLATIN AS FIRST-LINE INDUCTION OR MAINTENANCE, IN SUBJECTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER (ES-SCLC) Read more
A Multi-Center Phase II Randomized Trial of Immunotherapy versus Chemoimmunotherapy Guided by Circulating Tumor DNA Based Molecular Response on Patients with Metastatic NSCLC Read more
Determining the proportion of Cancer Center patients with certain diagnoses over the last two years who would be eligible for treatment with RefleXion Scintix technology. Read more
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma Read more
EA7211: A Randomized Phase III Study of Neoadjuvant Chemotherapy followed by Surgery versus Surgery Alone for Patients with High Risk RetroPeritoneal Sarcoma (STRASS 2) Read more
